Page 404 - ILAE_Lectures_2015

83. Group RCoPC. Glucocorticoid-Induced Osteoporosis: A Concise Guide to Prevention and Treatment. London:
Royal College of Physicians; 2003.

84. TRIVEDI DP, DOLL RD, KHAW KT. Effect of four monthly oral Vitamin D3 (cholecalciferol)
supplementation on fractures and mortality in men and women living in the community: randomised double
blind controlled trial. BMJ. 2003;326:469-472.

85. MIKATI MA, DIB L, YAMOUT B, SAWAYA R, RAHI AC, FULEIHAN GEH. Two randomized vitamin D
trials in ambulatory patients on anticonvulsants - Impact on bone. Neurology 2006;67(11):2005-2014.

86. MHRA. Antiepileptics: adverse effects on bone. Drug Safety Update 2009;2(9):2-2.
87. COLLINS N, MAHER J, COLE M, BAKER M, CALLAGHAN N. A prospective study to evaluate the dose of

vitamin-D required to correct low 25-hydroxyvitamin D levels, calcium and alkaline phosphatase in patients at
risk of developing antiepiletpic drug induced osteomalacia. Q J Med 1991;78(286):113-122.
88. NASHEF L, LAMB E. Vitamin D deficiency - Guidelines are needed for treating diseases of bone metabolism
in epilepsy. BMJ 1999;318(7193):1285-1285.
89. COMPSTON JE. Vitamin D deficiency - Guidelines are needed for treating diseases of bone metabolism in
epilepsy - Reply. BMJ 1999;318(7193):1285-1285.
90. SHETH RD. Bone health in epilepsy. Lancet Neurol 2004;3(9):516-516.
91. VIETH R, BISCHOFF-FERRARI H, BOUCHER BJ, et al. The urgent need to recommend an intake of vitamin
D that is effective. Am J Clin Nutr 2007;85(3):649-650.
92. KRISHNAMOORTHY G, NAIR R, SUNDAR U, KINI P, SHRIVASTAVA M. Early predisposition to
osteomalacia in Indian adults on phenytoin or valproate monotherapy and effective prophylaxis by simultaneous
supplementation with calcium and 25-hydroxy vitamin D at recommended daily allowance dosage: a
prospective study. Neurol India 2010;58(2):213-219.
93. DANQUAH-BOATEING D, COCK HR. Bone health advice in an adult epilepsy service: Re-audit of practice
and influence of national guidance. J Neurol 2014;261(suppl 1):S387-S387.
94. MINSHALL I, MAHON M, NELIGAN A. Bone protection and anti-epileptic drugs: The effect of audit and
computer messaging on supplementation prescribing practices. Seizure – Eur J Epilepsy 2013;22(9):757-759.
95. LAZZARI AA, DUSSAULT PM, THAKORE-JAMES M, et al. Prevention of bone loss and vertebral fractures
in patients with chronic epilepsy-Antiepileptic drug and osteoporosis prevention trial. Epilepsia
2013;54(11):1997-2004.
96. NISSEN-MEYER LS, SVALHEIM S, TAUBOLL E, GJERSTAD L, REINHOLT FP, JEMTLAND R. How
can antiepileptic drugs affect bone mass, structure and metabolism Lessons from animal studies. Seizure
2008;17(2):187-191.
97. BENICZKY SA, VIKEN J, JENSEN LT, ANDERSEN NB. Bone mineral density in adult patients treated with
various antiepileptic drugs. Seizure – Eur J Epilepsy 2012;21(6):471-472.
98. ELLIOTT JO, JACOBSON MP. Bone loss in epilepsy: Barriers to prevention, diagnosis, and treatment.
Epilepsy Behav 2006;8(1):169-175.
99. WASADE VS, SPANAKI M, IYENGAR R, BARKLEY GL, SCHULTZ L. AAN Epilepsy Quality Measures
in clinical practice: A survey of neurologists. Epilepsy Behav 2012;24(4):468-473.